Brief: Piramal Pharma Sept Quarter Consol Net Loss 992.2 Million Rupees
05/11/2025 15:35
Nov 5 (Reuters) - Piramal Pharma Ltd PIRM.NS: SEPT QUARTER CONSOL NET LOSS 992.2 MILLION RUPEES SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 20.44 BILLION RUPEES Source text: [ID:] Further company coverage: PIRM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio